You are here
Articles
Posted on Wednesday, November 24, 2021 - 1:22pm
CML Highlights of the 63rd ASH Annual Meeting
Posted on Thursday, October 7, 2021 - 1:32pm
iCMLF Knowledge Centre an interactive online resource providing educational content on CML patient management, options for molecular monitoring and
Posted on Friday, October 1, 2021 - 10:40am
What is D*action?
Posted on Tuesday, September 7, 2021 - 3:24pm
Conclusions: In this first controlled study comparing treatments for resistant/intolerant (R/I) pts with CML, asciminib, a first-in-class STAMP inhibitor, demonstrated statistically significant and...
Posted on Tuesday, September 7, 2021 - 2:28pm
Chronic myeloid leukemia (CML) is a blood cancer. Unlike other cancers CML treatment is lifelong and many patients experience side effects.
Posted on Friday, September 3, 2021 - 2:34pm
Conclusions: These updated results continue to support 50 mg of dasatinib daily as an effective and safe dose for newly diagnosed early CML-CP.
Posted on Monday, August 23, 2021 - 1:48pm
MyeloidScan – Long COVID in patients with myeloid blood cancers
Have you had COVID 19 infection? We need to find out more about long covid affects people like you – can you help us?
Posted on Wednesday, June 30, 2021 - 11:54am
A British Society for Haematology Guideline on the diagnosis and management of CML
Posted on Wednesday, June 30, 2021 - 11:31am
Clinical trials show that tyrosine kinase inhibitor (TKI) treatment can be discontinued in selected patients with chronic myeloid leukaemia (CML).
Posted on Sunday, May 16, 2021 - 3:22pm
Simple Summary
Posted on Friday, May 14, 2021 - 10:54am
Abstract
Posted on Thursday, February 4, 2021 - 1:02pm
Haematologica. 2020 Dec 1; 105(12): 2738–2745.Published online 2020 Oct 9. doi: 10.3324/haematol.2019.242891
Posted on Tuesday, January 26, 2021 - 3:35pm
Efficacy and Safety Results from ASCEMBL, a Multicenter, Open-Label, Phase 3 Study of Asciminib, a First-in-Class STAMP Inhibitor, vs Bosutinib (BOS) in Patients (Pts) with Chronic Myeloid Leukemia in Chronic...
Posted on Saturday, October 10, 2020 - 3:01pm
While the world eagerly awaits an effective vaccine, the current focus is on drug treatments.
Posted on Monday, August 31, 2020 - 5:49pm
In order to harmonize and standardize the management of patients with chronic myeloid leukemia (CML), the European LeukemiaNet (ELN) produced recommendations in the previous years.
- ‹ previous
- 2 of 33
- next ›